{"id":"W4311115611","doi":"10.1016/s0140-6736(22)02303-0","title":"Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"UCB Pharma; Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Medicine; Psoriatic arthritis; Placebo; Double blind; Psoriasis; Internal medicine; Arthritis; Dermatology; Gastroenterology; Oncology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002098336,0.001644608,0.003894199,0.0004068113,0.0005599092,0.001291579,0.0008712557,0.002635289,0.008556397],"category_scores_gemma":[0.001949257,0.00080318,0.002883389,0.0004972592,0.001119749,0.001171656,0.000537251,0.003339299,0.001393926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006855057,"about_ca_system_score_gemma":0.001139562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001375279,"about_ca_topic_score_gemma":0.003133745,"domain_scores_codex":[0.9992836,0.0003637259,0.00004647299,0.0001263538,0.00004950493,0.0001302742],"domain_scores_gemma":[0.99921,0.0002352591,0.0001734345,0.00006164918,0.00004853616,0.0002711542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9851265,0.001612057,0.000327289,0.0008087801,0.000908458,0.00003215847,0.00003368213,0.000115676,0.001360467,0.0000728843,0.0008986506,0.008703419],"study_design_scores_gemma":[0.987675,0.01089108,0.0006859484,0.00002264399,0.0002207939,0.00001936482,0.00001060991,0.00006233168,0.00006533743,0.00006136561,0.0002791728,0.000006448352],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9607271,0.02266315,0.001108092,0.002555678,0.002014009,0.004278068,0.002471013,0.00022706,0.003955885],"genre_scores_gemma":[0.9722489,0.008145801,0.002232396,0.003446263,0.001176092,0.005140506,0.001825236,0.00004904169,0.00573592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008556397,"threshold_uncertainty_score":0.028624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04186891445719548,"score_gpt":0.3044154919088538,"score_spread":0.2625465774516583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}